A Phase I/II Clinical Trial of Nivolumab in Progressive/Relapsed Pediatric Solid Tumors
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Nivolumab (Primary) ; Cyclophosphamide
- Indications Solid tumours
- Focus Therapeutic Use
- 28 Sep 2016 New trial record